Not exact matches
PD - L1 is often used as a
marker to indicate
if a
cancer might be responsive to immunotherapy, and usually the higher the PD - L1 level, the more responsive a
cancer would be to certain immunotherapies.
They found that women were five times as likely to develop
cancer if they had a higher percentage of Ki67, a molecular
marker that identifies proliferating cells, in the cells that line the mammary ducts and milk - producing lobules.
«
If the CD117 cell population does lead to tumor initiation or
cancer reoccurrence, this cell
marker could become a therapeutic target,» she says.
Comparing the
markers on these stem cells with those on the surfaces of
cancer cells, Johnson adds, will also help scientists determine
if stem cells contribute to prostate malignancies.
This means that, in the future, these particular cells could potentially be used as a
marker to monitor prostate
cancer patients and predict
if the disease is going to spread — alongside other monitoring techniques.
12/8/2008 Interactive Gene «Networks» May Predict
if Leukemia is Aggressive or Slow - Growing Rather than testing for individual
marker genes or proteins, researchers at the University of California, San Diego (UC San Diego) and the Moores UCSD
Cancer Center have evidence that groups, or networks, of interactive genes may be more reliable in... More...
It remains to be determined
if these genes are
markers of in utero estrogen exposure in breast
cancer patients.
We can envision that DAXX can serve as a precise prognostic
marker in PCa and that tissue - specific shRNA delivery targeted against DAXX can be employed in the treatment of metastatic prostate
cancer in patients, in particular
if we discover, through additional studies, that DAXX is a
marker for lethal PCa in humans.
«PTEN is a genomic
marker we already routinely measure, and based on published data we wanted to know
if we could use it to predict which BRCA1 / 2 mutated tumors are likely to respond to checkpoint inhibitors and which are not,» said the study's senior author Katherine L. Nathanson, MD, deputy director of the Abramson
Cancer Center and director of Genetics at the Basser Center for BRCA.
Considering that the hs - CRP inflammation
marker is associated with risk of diseases such as
cancer, dementia, cardiovascular disease, and many other chronic diseases, «
if you have to take one test, this might be the one.»
If an oncologist does a blood test for prostate
cancer, he looks for a tumor
marker called prostate specific antigen or PSA.
The good news is that
if markers for these tubal cells can be found, then blood tests, advanced Pap smears, or direct tests on tubal tissue might spot ovarian
cancer earlier, the study authors said.
(For example,
if you have had genetic testing and show the genetic
marker for predisposition for breast
cancer, your employer can not use that in making employment decisions.)